This can be attributed to the altered immunometabolism observed during basal NLRP3 activation linked with CAPS-associated variants, which, among others, impairs glycolysis curbing IL-1β production and limiting pathogenic inflammatory flares, while preserving a basal inflammatory status as a defence mechanism against pathogens. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.